Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
0.5754
-0.0246 (-4.10%)
At close: Jun 13, 2025, 4:00 PM
0.5909
+0.0155 (2.69%)
After-hours: Jun 13, 2025, 5:58 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022
Period Ending
Dec '23 Dec '22
Allogeneic Cell Therapies
2.24M
Log In
Allogeneic Cell Therapies Growth
-57.01%
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022
Period Ending
Dec '23 Dec '22
United States
2.24M
Log In
United States Growth
-57.01%
Log In